COVID-19 Infection in Diabetic Patients
Clinical Features of Diabetic Patients With COVID-19 Infection
1 other identifier
observational
300
1 country
1
Brief Summary
It was observed during the last period of COVID-19 pandemic that diabetic patients had a worse prognosis and more deteriorated clinical features than other patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2021
CompletedStudy Start
First participant enrolled
February 20, 2021
CompletedFirst Posted
Study publicly available on registry
February 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2021
CompletedFebruary 21, 2021
February 1, 2021
28 days
February 18, 2021
February 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Investigation of bad prognosis cause for covid-19 diabetic patients
number of diabetic patients with deteriorated case and to find the best hypoglycemic drug used for diabetic patients with covid-19 infection
30 days
Study Arms (2)
control group
COVID-19 infected patients with no other comorbidities and they take the routine protocol from the Egyptian ministry of health
diabetic group
COVID-19 infected patients with diabetes comorbidity and they receive the routine protocol for covid treatment in addition to their hypoglycemic drugs
Interventions
both groups will be monitored for the disease progress or deterioration and mortality rate
Eligibility Criteria
Patients infected with COVID-19 either diabetic or have no comorbidities, inpatients
You may qualify if:
- Patients infected with COVID-19 male or female 30 years old or more inpatients
You may not qualify if:
- have othe comorbidities other than type 2 diabetes mellitus pregnant women below 30 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University teaching hospitals
Cairo, Kasr Al Ainy, 11311, Egypt
Biospecimen
serum samoles for routine CBC, D dimer and INR tests
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of pharmacology
Study Record Dates
First Submitted
February 18, 2021
First Posted
February 21, 2021
Study Start
February 20, 2021
Primary Completion
March 20, 2021
Study Completion
April 10, 2021
Last Updated
February 21, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share